Bookmark
Forward
Explore Curated Studies Results
Explore Literature Results
Explore Clinical Trials Results
QuickView for Janus kinase, JAK
Most Correlated Studies
- Ovarian cancer model treated with JAK inhibitor AZD1480
- White-to-brown metabolic conversion of adipocytes by JAK inhibition
- Skin biopsies of atopic dermatitis patients treated with oral dual JAK/SYK inhibitor ASN002
- Epithelial cells from small airway treated with interferons, Baricitinib or Ruxolitinib
- CD4+ T cells activated under Th0 conditions with or without tofacitinib
Most Relevant Literature
- Janus kinase inhibition as a potential strategy for the treatment of psoriasis: state of the art and…
- Targeting the JAK-STAT pathway in lymphoma: a focus on pacritinib.
- De-regulation of JNK and JAK/STAT signaling in ESCRT-II mutant tissues cooperatively contributes to …
- Interleukin-6 signalling: more than Jaks and STATs.
- IL-7 downregulates IL-7Rα expression in human CD8 T cells by two independent mechanisms.
Most Relevant Clinical Trials
- Study to Evaluate Activity of 2 Dose Levels of Imetelstat in Participants With Intermediate-2 or Hig…
- Polymorphism of Janus Kinase 1 and 2 (JAK 1&2) in Patients With Alopecia Areata
- Comparative Study of Janus Kinase (JAK) Inhibitors Vs Tumor Necrosis Factor (TNF) Inhibitors in Rheu…
- A Study Comparing Imetelstat Versus Best Available Therapy for the Treatment of Intermediate-2 or Hi…
- Janus Kinase (JAK) Inhibitors to Preserve C-Peptide Production in New Onset Type 1 Diabetes (T1D)
